ABSK121-NX
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABSK121-NX, covering 2025-10-20 to 2025-10-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors [Phase 1]